Ulcerative ColitisSymptoms, Doctors, Treatments, Advances & More
Ulcerative Colitis Overview
Learn About Ulcerative Colitis
Cleveland Clinic Main Campus
Miguel Regueiro is a Gastroenterologist practicing medicine in Cleveland, Ohio. Dr. Regueiro is rated as an Elite provider by MediFind in the treatment of Ulcerative Colitis. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Ileostomy, and Colonoscopy. Dr. Regueiro is board certified in American Board Of Internal Medicine, 1997.
Stephen Hanauer is a Gastroenterologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 49 years. Dr. Hanauer is rated as an Elite provider by MediFind in the treatment of Ulcerative Colitis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Colonoscopy, and Endoscopy. Dr. Hanauer is board certified in American Board Of Internal Medicine - Gastroenterology (Certified).
Parambir Dulai is a Gastroenterologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 17 years. Dr. Dulai is rated as an Elite provider by MediFind in the treatment of Ulcerative Colitis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Viral Gastroenteritis, Ulcerative Colitis, Hemorrhagic Proctocolitis, Endoscopy, and Colonoscopy. Dr. Dulai is board certified in American Board Of Internal Medicine - Gastroenterology (Certified).
Summary: The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.
Summary: The study will evaluate patient and Health Care Professional- reported preference for Subcutaneous (SC) compared with IV nivolumab administration or similarly for SC compared with IV pembrolizumab.


